BackRhelion Life Sciences Overview

Rhelion Life Sciences Other Current Liabilities

Latest other current liabilities for TRUFF: $1.9M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$1.87M
↑ 164.75% YoYΔ $1.16M vs prior year quarter

Peer trimmed avg / median

Loading

Rhelion Life Sciences Other Current Liabilities History

Loading

Rhelion Life Sciences vs. peers: Other Current Liabilities Comparison

Loading

Rhelion Life Sciences Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Rhelion Life Sciences (TRUFF) FAQ

Rhelion Life Sciences's other current liabilities stands at $1.9M as of June 2026. That compares with $700K in the prior-year period — up 164.8% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Rhelion Life Sciences reported $1.9M in other current liabilities versus $700K a year earlier — a 164.8% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $700K in the prior-year period — up 164.8% year over year. Sustained growth in other current liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Rhelion Life Sciences's other current liabilities evolved across reporting periods, while the comparison chart places TRUFF next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Questions & Answers